 |
|
Alcohol-associated liver disease: Natural history, management and novel targeted therapies
Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós-Ginès, Ana Clemente-Sánchez, Hugo López-Pelayo, Ramón Bataller
Clin Mol Hepatol. 2025;31(Suppl):S112-S133. Published online 2024 Oct 31 DOI: https://doi.org/10.3350/cmh.2024.0709
|
|
Citations to this article as recorded by
 Naltrexone for Alcohol Use Disorder in Cirrhosis: Bridging the Gap in an Understudied Population
Romina Vergara-Quispe, David Marti-Aguado, Ramón Bataller
Journal of Clinical and Experimental Hepatology.2025; 15(2): 102509. CrossRef Larsucosterol Moves Forward as a Treatment Contender for Alcohol-Associated Hepatitis
Praveena Narayanan, Michael R. Lucey
NEJM Evidence.2025;[Epub] CrossRef
|